These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 358473)

  • 41. [Therapy of chronic viral hepatitis with interferon].
    Niederau C; Heintges T
    Internist (Berl); 1994 Jan; 35(1):70-7; discussion 77-9. PubMed ID: 7511573
    [No Abstract]   [Full Text] [Related]  

  • 42. Is it true what they say about interferon?
    Weimar W; Schellekens H
    N Engl J Med; 1979 Apr; 300(16):923-4. PubMed ID: 423945
    [No Abstract]   [Full Text] [Related]  

  • 43. [Interferon treatment of chronic viral hepatitis].
    Pirovino M
    Ther Umsch; 1992 May; 49(5):302-9. PubMed ID: 1377840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification of human fibroblast interferon prepared from modified fibroblasts.
    Tan YH
    Methods Enzymol; 1981; 78(Pt A):422-30. PubMed ID: 6173624
    [No Abstract]   [Full Text] [Related]  

  • 45. Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon.
    Blalock JE; Georgiades JA; Langford MP; Johnson HM
    Cell Immunol; 1980 Feb; 49(2):390-4. PubMed ID: 6986204
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical trials with exogenous interferon: summary of a meeting.
    Dunnick JK; Galasso GJ
    J Infect Dis; 1979 Jan; 139(1):109-23. PubMed ID: 220327
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of exogenous interferon and various interferon inducers on the indicators of general reactivity in systemic lupus erythematosus].
    Alekberova ZS; Barinskiĭ IF; Savinov VA; Pitenov VA; Kuznetsov VP
    Ter Arkh; 1980; 52(6):98-100. PubMed ID: 6157213
    [No Abstract]   [Full Text] [Related]  

  • 48. Letter: do interferon lambda 3 polymorphisms predict the outcome of interferon therapy in hepatitis B infection?
    Hadziyannis SJ; Laras A; Hadziyannis E
    Aliment Pharmacol Ther; 2014 May; 39(10):1250-1. PubMed ID: 24735152
    [No Abstract]   [Full Text] [Related]  

  • 49. Interferon, preclinical basis for clinical trials with fibroblast interferon in Japan.
    Kataoka T; Sakurai Y; Ida N; Kobayashi S
    Cancer Treat Rev; 1980 Dec; 7(4):253-6. PubMed ID: 6163536
    [No Abstract]   [Full Text] [Related]  

  • 50. Letter: do interferon lambda 3 polymorphisms predict the outcome of interferon therapy in hepatitis B infection? Authors' reply.
    Galmozzi E; Viganò M; Lampertico P
    Aliment Pharmacol Ther; 2014 May; 39(10):1251-2. PubMed ID: 24735153
    [No Abstract]   [Full Text] [Related]  

  • 51. Interferons: chemical properties.
    Fantes KH
    Tex Rep Biol Med; 1977; 35():173-80. PubMed ID: 358445
    [No Abstract]   [Full Text] [Related]  

  • 52. Molecular alterations of interferons.
    Stewart WE; Lin L; Chudzio T; Wiranowska-Stewart M
    Tex Rep Biol Med; 1977; 35():193-7. PubMed ID: 358448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interferon treatment in hepatitis B virus-associated membranous glomerulopathy.
    Kavukçu S; Başdemir G; Eroğlu Y; Türkmen M; Eser F; Büyükgebiz B
    Pediatr Nephrol; 1995 Aug; 9(4):539-40. PubMed ID: 7577424
    [No Abstract]   [Full Text] [Related]  

  • 54. [Therapeutic strategy for viral hepatitis].
    Omata M
    Nihon Naika Gakkai Zasshi; 2004 Sep; 93(9):1997-2004. PubMed ID: 15515696
    [No Abstract]   [Full Text] [Related]  

  • 55. Tolerability of pure fibroblast interferon in man.
    Billiau A; Heine JW; Van Damme J; Heremans H; De Somer P
    Ann N Y Acad Sci; 1980; 350():374-5. PubMed ID: 6165288
    [No Abstract]   [Full Text] [Related]  

  • 56. Interferon therapy: pharmacokinetic and pharmacological aspects.
    Billiau A
    Arch Virol; 1981; 67(2):121-33. PubMed ID: 6163417
    [No Abstract]   [Full Text] [Related]  

  • 57. [Comparative study of the biological properties of swine and human leukocyte interferons].
    Solov'ev VD; Ogarkov VI; Marchenko VI; Monastyreva LA; Pokidysheva LN
    Vopr Virusol; 1980; (6):663-6. PubMed ID: 6164159
    [No Abstract]   [Full Text] [Related]  

  • 58. Interferon from blood leukocytes.
    Mogensen KE
    Rev Fr Transfus Immunohematol; 1980; 23(3):373-97. PubMed ID: 6157398
    [No Abstract]   [Full Text] [Related]  

  • 59. The status of interferon.
    Burke DC
    Sci Am; 1977 Apr; 236(4):42-50. PubMed ID: 265626
    [No Abstract]   [Full Text] [Related]  

  • 60. Immune interferon activates cells more slowly than does virus-induced interferon.
    Dianzani F; Salter L; Fleischmann WR; Zucca M
    Proc Soc Exp Biol Med; 1978 Oct; 159(1):94-7. PubMed ID: 714938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.